BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15458920)

  • 1. Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma.
    Nie W; Sweetser S; Rinella M; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G207-12. PubMed ID: 15458920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
    Mazzucotelli A; Viguerie N; Tiraby C; Annicotte JS; Mairal A; Klimcakova E; Lepin E; Delmar P; Dejean S; Tavernier G; Lefort C; Hidalgo J; Pineau T; Fajas L; Clément K; Langin D
    Diabetes; 2007 Oct; 56(10):2467-75. PubMed ID: 17646210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
    Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
    Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
    Han KL; Choi JS; Lee JY; Song J; Joe MK; Jung MH; Hwang JK
    Diabetes; 2008 Mar; 57(3):737-45. PubMed ID: 18065517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
    Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
    Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha and its response element are required but not sufficient for transcriptional activation of the mouse heart-type fatty acid binding protein gene.
    Kawabe K; Saegusa H; Seto K; Urabe H; Motojima K
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1534-46. PubMed ID: 15833283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
    Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
    Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
    Zheng S; Chen A
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G113-23. PubMed ID: 16959952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
    Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
    Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-γ in the regulation of macrophage inflammatory protein-3α at early onset of diabetes.
    Qi W; Holian J; Tan CY; Kelly DJ; Chen XM; Pollock CA
    Int J Biochem Cell Biol; 2011 Mar; 43(3):383-92. PubMed ID: 21109018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocarboxylate transporter 1 and CD147 are up-regulated by natural and synthetic peroxisome proliferator-activated receptor alpha agonists in livers of rodents and pigs.
    König B; Fischer S; Schlotte S; Wen G; Eder K; Stangl GI
    Mol Nutr Food Res; 2010 Sep; 54(9):1248-56. PubMed ID: 20306479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1/SLC22A1).
    Kajiwara M; Terada T; Asaka J; Aoki M; Katsura T; Ikai I; Inui K
    Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1211-6. PubMed ID: 18845576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
    Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
    Shock; 2006 Sep; 26(3):262-70. PubMed ID: 16912651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
    Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
    J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis.
    Koch A; König B; Stangl GI; Eder K
    Exp Biol Med (Maywood); 2008 Mar; 233(3):356-65. PubMed ID: 18296741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARalpha agonists up-regulate organic cation transporters in rat liver cells.
    Luci S; Geissler S; König B; Koch A; Stangl GI; Hirche F; Eder K
    Biochem Biophys Res Commun; 2006 Nov; 350(3):704-8. PubMed ID: 17011512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.
    Subbarayan V; Sabichi AL; Kim J; Llansa N; Logothetis CJ; Lippman SM; Menter DG
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1710-6. PubMed ID: 15533897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.